Clinical Trial Update: A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments

View source ↗

Summary

A completed clinical trial examined participants' perspectives beyond clinical efficacy of monoclonal antibody–based treatments for relapsing-remitting multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: COMPLETED